Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

He was joined by Dr. Alex Oshmyansky, the CEO and cofounder of the Mark Cuban Cost Plus Drug Company, a low-cost drug ...

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...

Mark Cuban is game to chat on social media—just not necessarily on X, formerly Twitter, he told the Fortune Brainstorm ...

If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs would be available at cost plus 15%, and the amount of money spent on drugs would decline ...

The Mark Cuban Cost Plus Drug Company (MCCPDC) – a public-benefit corporation and online pharmacy that launched in 2022 with a pledge to eliminate middlemen markups on off-patent drugs and pass ...

If the prescribed treatment is Eli Lilly's ... other companies moved to simplify the system in recent months. Cost Plus Drugs ...

Amgen is on pace to return to its pre-Horizon capital structure by the end of 2025. Learn why I upgrade AMGN stock from hold ...

The year 2024 was arguably the last time in the current Marcos administration that seeking constitutional revision was ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...